Business
Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations
Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to
About this update from Ocular Therapeutix, Inc.
[{"type":"text","content":"Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will present detailed results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI™ (also known as OTX-TKI), for the treatment of wet age-related macular degeneration (wet AMD), at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, with data presentations starting at 1:00 PM PT (4:00 PM ET). Ocular plans to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations. 49th Macula Society Annual Meeting: February 25 – 28, 2026San Diego, California Symposium Title: Ocular Therapeutix Symposium to Review Detailed SOL-1 DataSymposium Date/Time: Friday, February 27, 2026, 12:45 – 2:15 PM PT. Following welcome remarks, SOL-1 data presentations to begin at 1:00 PM PT (4:00 PM ET). The SOL-1 Symposium slides will be made available by a Current Report on Form 8-K to be furnished to the Securities and Exchange Commission (SEC) at 4:00 PM ET on Friday, February 27, 2026. Ocular also plans to make a copy of all slides presented at the 49th Macula Society Annual Meeting available on its website. SOL-1 Detailed Data Investor Webcast: March 2, 2026Ocular Therapeutix will host a conference call and webcast to discuss the detailed SOL-1 results being presented at the 49th Macula Society Annual Meeting. The event will include brief prepared remarks followed by a live Q&A session with Ocular leadership and retina Key Opinion Leaders. Conference Call and Webcast InformationDate/Time: Monday, March 2, 2026, at 7:30 AM ETParticipant Dial-In (U.S.): 1-800-579-2543Participant Dial-In (International): 1-785-424-1789Conference ID: OCULARWebcast Access: Please click here The live and archived webcast can also be accessed by visiting the Ocular Therapeutix website on the Events and Presentations section of the Investor Relations page. A replay of the webcast will be archived for at least 30 days. About Ocu...